Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modulation of Morphine Analgesia, Antinociceptive Tolerance, and Mu-Opioid Receptor Binding by the Cannabinoid CB2 Receptor Agonist O-1966.

Frontiers in pharmacology·2022
Same author

Opioid-sparing effects of cannabinoids on morphine analgesia: participation of CB<sub>1</sub> and CB<sub>2</sub> receptors.

British journal of pharmacology·2019
Same author

Single and combined effects of Δ<sup>9</sup> -tetrahydrocannabinol and cannabidiol in a mouse model of chemotherapy-induced neuropathic pain.

British journal of pharmacology·2017
Same author

Drug Combinations: Tests and Analysis with Isoboles.

Current protocols in pharmacology·2016
Same author

Levamisole enhances the rewarding and locomotor-activating effects of cocaine in rats.

Drug and alcohol dependence·2015
Same author

Distinct interactions of cannabidiol and morphine in three nociceptive behavioral models in mice.

Behavioural pharmacology·2014

Related Experiment Video

Updated: May 21, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

Quantitative methods for assessing drug synergism.

Ronald J Tallarida1

  • 1Temple University School of Medicine, Philadelphia, PA, USA.

Genes & Cancer
|June 28, 2012
PubMed
Summary
This summary is machine-generated.

Synergistic drug interactions occur when combined drug effects exceed predicted levels, enabling lower doses and potentially fewer side effects. This review details methods for quantitatively assessing drug synergy using dose equivalence and isobolographic analysis.

Keywords:
additivitydose-effect relationdrug combinationsisobolesoptimal dose strategysubadditivitysynergism

More Related Videos

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

Related Experiment Videos

Last Updated: May 21, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

Area of Science:

  • Pharmacology
  • Drug Interaction Studies
  • Quantitative Analysis

Background:

  • Drug combinations are frequently used in treating various diseases, including cancer, infections, and pain.
  • Synergism, where combined drug effects are greater than additive, offers potential benefits like reduced adverse reactions.
  • Quantifying drug synergy requires rigorous demonstration exceeding expected individual potencies.

Purpose of the Study:

  • To explain the concept of dose equivalence as the basis for assessing drug synergy.
  • To present isobolographic analysis and related methods for quantitative synergy determination.
  • To provide a mathematical framework for synergy assessment and dose combination optimization.

Main Methods:

  • Discussion of dose equivalence principles.
  • Application of isobolographic analysis for experimental design and data interpretation.
  • Presentation of related analytical methods utilizing dose equivalence.

Main Results:

  • The review provides the mathematical basis for assessing drug synergy.
  • It outlines an optimization strategy for determining effective drug dose combinations.
  • Isobolugraphic analysis is presented as a key method for demonstrating synergy.

Conclusions:

  • Accurate assessment of drug synergy is crucial for optimizing combination therapies.
  • Dose equivalence and isobolographic analysis are fundamental tools for quantifying synergistic drug interactions.
  • Understanding these principles can lead to improved therapeutic strategies with reduced toxicity.